World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
110
Citations
69117
World Ranking
871
National Ranking
527

Medicine

D-Index
111
Citations
72547
World Ranking
5233
National Ranking
2825

Laura J. van't Veer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Laura J. van't Veer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 481 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Laura J. van't Veer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Laura J. van't Veer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Laura J. van't Veer is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, and Pulmonary and Respiratory Medicine.

Their scholarly work focuses on several core topics within cancer research and treatment. Key areas include Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Radiomics and Machine Learning in Medical Imaging, Cancer Genomics and Diagnostics, Medical Imaging Techniques and Applications, MRI in cancer diagnosis, and Advanced Breast Cancer Therapies.

Frequent co-authors collaborating with Laura J. van't Veer include:

  • Laura J. Esserman
  • Christina Yau
  • Nola M. Hylton
  • Hope S. Rugo
  • Claudine Isaacs

The scientist has published extensively in several venues, with the most frequent publication outlets being:

  • Cancer Research
  • Annals of Oncology
  • UNC Libraries
  • Breast Cancer Research and Treatment
  • npj Breast Cancer

Recent notable papers authored or co-authored by Laura J. van't Veer include:

  • "Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial," 2021, Cancer Cell
  • "Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer," 2020, JAMA Oncology
  • "MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial," 2020, Journal of Clinical Oncology
  • "ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer," 2023, Proceedings of the National Academy of Sciences
  • "Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer," 2021, npj Breast Cancer

Best Publications

  • Gene expression profiling predicts clinical outcome of breast cancer

    Laura J. van 't Veer;Hongyue Dai;Marc J. van de Vijver;Yudong D. He

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

    Timothy R. Rebbeck;Henry T. Lynch;Susan L. Neuhausen;Steven A. Narod

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Concordance among Gene-Expression–Based Predictors for Breast Cancer

    Cheng Fan;Daniel S Oh;Lodewyk Wessels;Britta Weigelt

  • Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

    Katherine A. Hoadley;Christina Yau;Denise M. Wolf;Andrew D. Cherniack

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

    Miranda L. Broz;Mikhail Binnewies;Bijan Boldajipour;Amanda E. Nelson

  • Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

    Howard Y. Chang;Dimitry S. A. Nuyten;Julie B. Sneddon;Trevor Hastie

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    F. Cardoso;A. Costa;L. Norton;E. Senkus

  • A common coding variant in CASP8 is associated with breast cancer risk

    Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian

  • Enabling personalized cancer medicine through analysis of gene-expression patterns

    Laura J. van 't Veer;René Bernards

  • Refinement of breast cancer classification by molecular characterization of histological special types.

    B Weigelt;H M Horlings;B Kreike;M M Hayes

  • Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

    Ramon Salazar;Paul Roepman;Gabriel Capella;Victor Moreno

  • Converting a breast cancer microarray signature into a high-throughput diagnostic test.

    Annuska M. Glas;Arno Floore;Leonie Jmj M. J. Delahaye;Anke T. Witteveen

  • Gene expression profiles of primary breast tumors maintained in distant metastases.

    Britta Weigelt;Annuska M. Glas;Lodewyk F. A. Wessels;Anke T. Witteveen

  • Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau

  • Clinical application of the 70-gene profile: the MINDACT trial.

    Fatima Cardoso;Laura Van't Veer;Emiel Rutgers;Sherene Loi

Frequent Co-Authors

Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Christina Yau
Christina Yau University of California, San Francisco
Marjanka K. Schmidt
Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Annegien Broeks
Annegien Broeks Antoni van Leeuwenhoek Hospital
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Angela DeMichele
Angela DeMichele University of Pennsylvania
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Douglas F. Easton
Douglas F. Easton University of Cambridge
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a variety of online healthcare degrees and certifications. For those seeking to advance their clinical expertise, best online dnp programs offer flexible, high-level nursing training that prepares practitioners for leadership roles.

Pharmacy professionals can benefit from affordable distance education options as well. While evaluating online pharmacy school cost, students can find accessible programs that fit a range of budgets and schedules.

Not all healthcare careers are patient-facing. Administrative and information sectors are growing rapidly. Earning credentials from rhia certification programs online can lead to in-demand roles managing medical data and compliance.

If you’re interested in insurance or healthcare finance, attaining a recognized qualification through an affordable medical billing and coding certification cost can quickly open new career opportunities in this vital field.

Best Scientists Citing Laura J. van't Veer

Trending Scientists